Polymorph control of sulfathiazole in supercritical CO2

被引:81
作者
Kordikowski, A
Shekunov, T
York, P
机构
[1] Bradford Particle Design Plc, Bradford BD7 1HR, W Yorkshire, England
[2] Univ Bradford, Sch Pharm, Drug Delivery Grp, Bradford BD7 1DP, W Yorkshire, England
关键词
sulfathiazole; polymorph; supercritical fluid; enantiotropes;
D O I
10.1023/A:1011045729706
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Sulfathiazole was used to investigate polymorph control in Liquid and supercritical CO2. Conventional techniques require a variety of solvents and techniques to produce different polymorphs. The present approach involves precipitation from an organic solution with liquid or supercritical CO2 using the SEDS (TM) process. Methods. Sulfathiazole was precipitated from methanol or acetone solutions. Experiments were carried out within a temperature range of 0-120 degreesC. Composition of the fluid phase was varied between x(CO2) = 0.27-0.99. Pressure was constant at 700 bar. Samples obtained were analyzed using SEM, DSC, and XRPD. Results. Pure polymorphs were obtained at different temperatures and flow rate ratios of CO2/solvent. With methanol Form I, III, and IV and their mixtures could be crystallized. With acetone Form I or a mixture of Form I and amorphous sulfathiazole was obtained. The fluid composition was used as a control parameter to define the process areas (T-x diagram) where the purr forms or mixtures of different forms could be obtained. Conclusions, The experiments enabled the relationship between flow and temperature for each polymorph to be determined. The crystallization method developed proved to be a simple and efficient technique for reproducible and consistent isolation of sulfathiazole polymorphs.
引用
收藏
页码:682 / 688
页数:7
相关论文
共 27 条
[1]  
[Anonymous], [No title captured]
[2]   POLYMORPHISM OF SULFATHIAZOLE [J].
ANWAR, J ;
TARLING, SE ;
BARNES, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (04) :337-342
[3]  
ANWAR J, 1993, J PHYS D, V26, pB90
[4]   Sulfathiazole polymorphism studied by magic-angle spinning NMR [J].
Apperley, DC ;
Fletton, RA ;
Harris, RK ;
Lancaster, RW ;
Tavener, S ;
Threlfall, TL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (12) :1275-1280
[5]  
BABILEV FV, 1987, KHIM FARM ZH+, V21, P1275
[6]   Control of the physical form of salmeterol xinofoate [J].
Beach, S ;
Latham, D ;
Sidgwick, C ;
Hanna, M ;
York, P .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 1999, 3 (05) :370-376
[7]   Crystal chemistry and solvent effects in polymorphic systems - Sulfathiazole [J].
Blagden, N ;
Davey, RJ ;
Lieberman, HF ;
Williams, L ;
Payne, R ;
Roberts, R ;
Rowe, R ;
Docherty, R .
JOURNAL OF THE CHEMICAL SOCIETY-FARADAY TRANSACTIONS, 1998, 94 (08) :1035-1044
[8]   Disappearing polymorphs and the role of reaction by-products: the case of sulphathiazole [J].
Blagden, N ;
Davey, RJ ;
Rowe, R ;
Roberts, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 172 (1-2) :169-177
[9]  
Brittain H. G., 1999, Polymorphism in Pharmaceutical Solids
[10]  
BURGER A, 1983, PHARM ACTA HELV, V58, P72